0 results available. Select is focused ,type to refine list, press Down to open the menu,
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the ...
The following section summarizes insights on GlaxoSmithKline PLC's Market Cap / LTM Revenue:
We've identified the following companies as similar to GlaxoSmithKline PLC because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Market Cap / LTM Revenue in the valuation category include:
Indicates the multiple of revenue that stock investors are willing to pay for one share of the firm.
Market Cap / LTM Revenue also known as Price / Sales, or P/S ratio is a financial ratio that compares a company’s market capitalization to the amount of revenue the company earned during the last 12 months.
P/S Ratio = Market Cap / LTM Revenue
Applying this formula, GSK’s P/S Ratio is calculated below:
Market Capitalization [ £57.625 B ]
(/) Revenue [ £30.348 B ]
(=) P/S Ratio [ 1.9x ]
Equivalently, it can also be calculated by dividing the per-share stock price by the per-share projected revenue.
The tables below summarizes the trend in GSK’s P/S Ratio over the last five years:
| Date | Market Cap | Revenue | P/S Ratio |
|---|---|---|---|
| 2020-12-31 | £66.801 B | £34.259 B | 1.9 |
| 2021-12-31 | £80.458 B | £26.359 B | 3.1 |
| 2022-12-31 | £58.381 B | £29.024 B | 2.0 |
| 2023-12-31 | £59.112 B | £29.652 B | 2.0 |
| 2024-12-31 | £54.944 B | £28.936 B | 1.9 |
Read more about the ratio on Wikipedia, sales and market capitalization.
The chart above depicts the distribution of market cap / ltm revenue for companies operating in the Healthcare sector in the Developed economic region. Over 1,950 companies were considered in this analysis, and 1,875 had meaningful values. The average market cap / ltm revenue of companies in the sector is 26.3x with a standard deviation of 95.2x.
GlaxoSmithKline PLC's Market Cap / LTM Revenue of 1.9x ranks in the 43.1% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,953 |
| Included Constituents | 1,875 |
| Min | 0.0x |
| Max | 1,031.0x |
| Median | 2.6x |
| Mean | 26.3x |
| Standard Deviation | 95.2x |
You can find companies with similar market cap / ltm revenue using this stock screener.